Eli Lilly just released Phase 3 data on Retatrutidea "triple agonist" that makes current GLP-1 drugs look like first drafts
Malik IO, Petersen MC, Klein S
The documented criteria for Mounjaro are: confirmed T2D diagnosis (ICD-10 E11.x), A1c of 6.5% or greater within approximately 90 days, and a documented trial or failure of metformin (plus often one additional oral agent)
The whole process is pretty simple
Sheveleva EV, Landowski TH, Samulitis BK, Bartholomeusz G, Powis G, Dorr RT
GHK-Cu exists as a 1:1 copper(II):peptide complex in which the Cu(II) ion is coordinated by the glycine terminal amino group, the amide nitrogen between glycine and histidine, the histidine imidazole nitrogen, and the lysine side chain amino group in a square planar arrangement